Significance of Monitoring Plasma Levels of Neuroleptics in Treatment of Schizophrenic Patients
DOI:
https://doi.org/10.5644/Radovi.255Abstract
According to many investigations in the past decade monitoring plasma levels of neuroleptics would be of great importance in treatment of schizophrenic patients. Plasma levels of neuroleptics in our studies correlated with the peripheric and the Central psychophysiological tests, psychiatric rating scales, cognitive and biochemical tests. The measuring of plasma concentration of neuroleptics is still now in the field of the scientific investigation. However, it is possible to monitor plasma levels of neuroleptics indirectly — using these tests.
Author discussed the conditions when it is necessary to monitor plasma levels of neuroleptics.
References
Alfredson, G., Sedvall, G., F. A. Wiesel and Wodehelgodt, B. (1980): The relevance of measuring chlorpromazine concentration in serum. Phenothiazine and structuraly related drugs: Basic and clinical studies (Ed. E. Usedin et al.) 7, 199—202.
Davis, M. J, Erickson, S. and H. Dekirmenjian (1978): Plasma Levels of Antipsychotic drug and Clinical Response. Psychopharm. A Gener. of Progress (Ed. Lipton et al.) Raven Press, N. Y. 905—915.
Jovanović, M- (1983): Efikasnost kombinovane terapije depo oblicima neuroleptika u liječenju shizofrene psihoze. Magistarski rad, Medicinski fakultet, Sarajevo.
Jovanović, M. iS. Loga (1983): Kombinacija dva depo-neuroleptika u produženom liječenju shizofrenih bolesnika, Zbornik rezimea, Pula, 1984.
Kučukalić, A.: Liječenje shizofrene psihoze sa kombinovanom neuroleptičkom terapijom u retard-obliku. Magistarski rad, Medicinski fakulltet, Sarajevo.
Loga, S., Curry S. and Lader M. (1975): Interactions of orphenadrine and phenobarbitone with chlorpromazine: plasma concentrations and effects in man. Brit. J. Clin. Pharmac. 2, 197—208.
Loga, S. (1918):Mogućnosti praćenja koncentracije psihotropnih lijekova u plazmi psihijatrijskih bolesnika. Kongresne teme, Split, 92.
Loga, S., Š. Tafro, E. Rustempašić, M. Jovanović i A. Kučukalić (1980): Metodološki pristup evaluciji efekata kombinovane terapije u produženom liječenju shizofrene psihoze. Psihijatrija, Zajednica, Sarajevo, 404—405.
Loga, S., Curry S. and Lader M. (1981): Interaction of Chloropromazine and Nertryptyline in Patients with Schizophrenia. Clin. Pharmacokin. 6, 454—462.
Loga, S. (1981): Antipirinski test u funkciji racionalne neuroleptične terapije. Zbornik radova, 2 kongres Ijekara BiH, Sarajevo, 468—471.
Loga, S. (1984): Uticaj fenobarbitona na nivo hlorpromazina u krvi bolesnika i efekti ove terapije. Knjiga sažetaka III Jugoslovenskog kongresa za EEG i kliničku neurofiziologiju, Zadar, 124.
Loga, S. i M. Jovanović (1983): Upoređivanje dužine rukopisa i plazma nivoa flufenazin dekanoata kod shizofrenih bolesnika liječenih flufenazin dekanoatom i penfluoridolom. Engrami, 1—2, 1—7.
Nikoli n, B., M. Lekić, S. Loga, E. Rustempašić i A. Kučukalić (1982): Analitika neuroleptika metodom gasne hromatografije. III Jugoslovenski simpozij iz analitičke hernije. Novi Sad, Zbornik radova, 21.
Rustempašić, E. (1983): Kombinovano dejstvo depo i peroralne forme neuroleptika u terapiji hroničnih shizofrenih psihoza. Magistarski rad, Medicinski fakultet, Sarajevo.
Sakalis, G., S. H. Curry, P. Mould and M. Lader (1972): Physiologic and clinic effects of chlorpromazine and their relationship to plasma level, Clin. Pharmac. and Therap. 13, 931—946.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Slobodan Loga
This work is licensed under a Creative Commons Attribution 4.0 International License.
